Skip to content

Accuracy Evaluation of Artificial Intelligence Assisted Liver Tumor Ablation Path Planning

Accuracy Evaluation of Artificial Intelligence Assisted Liver Tumor Ablation Path Planning

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05161624
Enrollment
160
Registered
2021-12-17
Start date
2021-12-15
Completion date
2022-04-30
Last updated
2021-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Tumor

Keywords

liver tumor, ablation, path planning, artificial intelligence, accuracy evaluation

Brief summary

CT-guided microwave ablation is one of the important treatment methods for primary or metastatic liver tumors. It has the advantages of minimally invasive, safe, and economical. For liver tumors with a diameter of less than 3 cm, it can be comparable to surgical resection. However, different doctors have different levels of experience, leading to a high risk of residues after ablation and even complications. The key is to fail to plan the needle placement reasonably. The past research on path planning was mostly conducted by the engineering team, so that the actual clinical needs were not considered comprehensively, and the sample size of verified cases was small, which limited the application of existing models in the clinical application. In previous study, we used artificial intelligence to segment the upper abdominal organs and construct the constraint function to establish the ablation path planning model, and initially verified the effectiveness of the path planning model in a small number of cases. Now it is planned to expand the number of patients enrolled to evaluate the accuracy of the ablation path planning model that we have established.

Interventions

DIAGNOSTIC_TESTAccuracy evaluation

The design of the diagnostic trial will include 160 cases of liver tumors with indications for microwave ablation after a multidisciplinary consultation with clinicians (Multiple Disciplinary Team, MDT), including primary liver cancer and metastatic liver tumors, and the tumor diameter is less than 3 cm. The test subjects consist of three groups: a. path planning model, b. junior ablation specialists, c. senior ablation specialists. The three groups will perform microwave ablation path planning on 160 selected cases of liver tumors. The attending professor of the clinical medical group of the department is responsible for scoring, evaluating whether the design of the plan is reasonable, and then comparing the scoring results by using statistical methods to evaluate the accuracy and effectiveness of the path planning model established in this study.

Sponsors

Sun Yat-sen University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years

Inclusion criteria

1. 18-70 years old patients with liver tumors, not limited to primary liver cancer or secondary liver metastases; 2. The number of tumors is less than 5; 3. The diameter of the tumor is less than 3 cm; 4. No local treatment of intrahepatic tumors has been done in the past.

Exclusion criteria

1. Diffuse liver tumor; 2. Multiple lesions in the liver\> 3cm, which cannot be completely ablated; 3. Patients with lymph node metastasis and distant metastasis outside the liver; 4. Other situations where the researcher believes that it is necessary to withdraw from the study

Design outcomes

Primary

MeasureTime frame
Receiver operating characteristic curve, ROC2 years

Secondary

MeasureTime frame
Area under curve, AUC2 years

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026